sotalol has been researched along with albuterol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Aué, GH; Bultsma, T; IJzerman, AP; Linschoten, MR; Timmerman, H | 1 |
| Hadzi, D; Lukovits, I; Solmajer, T | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kostopoulos, GK; Phillis, JW | 1 |
| Abel, P; Buckner, CK | 1 |
| Day, MD; Roach, AG | 1 |
| Lockwood, RH; Lum, BK | 1 |
| Gerber, JG; Nies, AS; Olson, RD | 1 |
| Bonta, IL; Schenkelaars, EJ | 1 |
| Coleman, RA; Johnson, M; Nials, AT; Sumner, MJ | 1 |
| Bergendal, A; Lindén, A; Löfdahl, CG; Skoogh, BE; Ullman, A | 1 |
| Kim, KJ; Lee, VH; Mathias, NR | 1 |
| Antony Muthu Prabhu, A; Rajendiran, N; Subramanian, VK | 1 |
| Li, L; Li, X; Luo, Q; You, T | 1 |
2 review(s) available for sotalol and albuterol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
21 other study(ies) available for sotalol and albuterol
| Article | Year |
|---|---|
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; Dihydroalprenolol; Ethanolamines; Guanylyl Imidodiphosphate; Hydrogen-Ion Concentration; Muscles; Propanolamines; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1985 |
Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain.
Topics: Chemical Phenomena; Chemistry, Physical; Electrochemistry; Molecular Conformation; Phenethylamines; Receptors, Adrenergic; Structure-Activity Relationship | 1982 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Activation of a noradrenergic pathway from the brain stem to rat cerebral cortex.
Topics: Albuterol; Animals; Brain Stem; Cerebral Cortex; Electric Stimulation; Hydroxydopamines; Locus Coeruleus; Male; Neural Pathways; Norepinephrine; Phenylephrine; Rats; Sotalol | 1977 |
Studies on the effects of enantiomers of soterenol, trimetoquinol and salbutamol on beta adrenergic receptors of isolated guinea-pig atria and trachea.
Topics: Adrenergic beta-Agonists; Albuterol; Anilides; Animals; Benzyl Compounds; Dose-Response Relationship, Drug; Ethanolamines; Female; Guinea Pigs; Heart Atria; In Vitro Techniques; Isomerism; Isoproterenol; Isoquinolines; Muscle Contraction; Phenethylamines; Phenoxybenzamine; Phentolamine; Receptors, Adrenergic; Sotalol; Sulfonamides; Trachea | 1974 |
Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.
Topics: Albuterol; Alprenolol; Animals; Atropine; Bethanidine; Blood Pressure; Cats; Cerebral Ventricles; Clonidine; Dopamine; Epinephrine; Female; Heart Rate; Hexamethonium Compounds; Injections; Isoproterenol; Lidocaine; Male; Norepinephrine; Pempidine; Phentolamine; Practolol; Propranolol; Rabbits; Rats; Receptors, Adrenergic; Sotalol; Species Specificity; Time Factors | 1974 |
Effects of adrenergic agonists and antagonists on potassium metabolism.
Topics: Albuterol; Animals; Blood Glucose; Blood Pressure; Butoxamine; Cats; Epinephrine; Ethanolamines; Heart Rate; Hyperkalemia; Isoproterenol; Norepinephrine; Pancreas; Phenethylamines; Phenoxybenzamine; Phenylephrine; Potassium; Potassium Chloride; Practolol; Propanolamines; Propranolol; Propylamines; Sotalol; Sulfonamides; Sympatholytics; Sympathomimetics; Thiazoles; Time Factors; Toluene | 1974 |
Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Dogs; Female; Indomethacin; Isoproterenol; Kidney; Male; Propanolamines; Receptors, Adrenergic; Receptors, Adrenergic, beta; Renin; Sotalol; Stimulation, Chemical | 1982 |
Beta 2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages.
Topics: Adrenergic beta-Antagonists; Albuterol; Animals; Drug Interactions; Ephedrine; Glucuronidase; Isoproterenol; Lysosomes; Macrophages; Male; Peritoneum; Prostaglandins E; Rats; Rats, Inbred Strains; Sotalol; SRS-A; Thromboxane B2 | 1984 |
Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Isoproterenol; Lung; Male; Muscle Relaxation; Muscle, Smooth; Perfusion; Radioligand Assay; Rats; Salmeterol Xinafoate; Sotalol; Time Factors | 1993 |
Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Carbachol; Dose-Response Relationship, Drug; Ethanolamines; Female; Formoterol Fumarate; Guinea Pigs; Muscle Relaxation; Salmeterol Xinafoate; Sotalol; Trachea | 1993 |
Targeted drug delivery to the respiratory tract: solute permeability of air-interface cultured rabbit tracheal epithelial cell monolayers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Biological Transport; Cell Membrane Permeability; Cells, Cultured; Dextrans; Epithelium; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Male; Molecular Weight; Rabbits; Sotalol; Trachea | 1996 |
Excimer formation in inclusion complexes of β-cyclodextrin with salbutamol, sotalol and atenolol: spectral and molecular modeling studies.
Topics: Absorption; Acetonitriles; Albuterol; Atenolol; beta-Cyclodextrins; Electrons; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Nanostructures; Protons; Solvents; Sotalol; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Thermodynamics; Time Factors; Water | 2012 |
A comprehensive study of the enantioseparation of chiral drugs by cyclodextrin using capillary electrophoresis combined with theoretical approaches.
Topics: Albuterol; Benzyl Alcohols; beta-Cyclodextrins; Electrophoresis, Capillary; Magnetic Resonance Spectroscopy; Models, Molecular; Sotalol; Stereoisomerism | 2015 |